The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines

BACKGROUND: General control nonderepressible 2 (GCN2) senses amino acid deprivation and activates activating transcription factor 4 (ATF4), which regulates many adaptive genes. We evaluated the impact of AST-0513, a novel GCN2 inhibitor, on the GCN2-ATF4 pathway. Additionally, we evaluated the antit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeongjae, Keam, Bhumsuk, Kim, Soyeon, Heo, Jung-Nyoung, Joung, Eunkyo, Kim, Miso, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694079/
https://www.ncbi.nlm.nih.gov/pubmed/36436443
http://dx.doi.org/10.1016/j.tranon.2022.101592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694079/
https://www.ncbi.nlm.nih.gov/pubmed/36436443
http://dx.doi.org/10.1016/j.tranon.2022.101592

Ejemplares similares